Wide Ranks

DAWN

Day One Biopharmaceuticals, Inc

13.72

Top Statistics
Market Cap 1 B Forward PE -12.27 Revenue Growth 0.00 %
Current Ratio 14.62 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -82.68 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -4.03 Enterprise / Revenue 8.12 Price To Sales Trailing12 Months 13.57
Profitability
Profit Margins -82.68 % Operating Margins 31.61 %
Balance Sheet
Total Cash 558 M Total Cash Per Share 5.54 Total Debt 2 M
Total Debt To Equity 0.4710 Current Ratio 14.62 Book Value Per Share 5.51
All Measures
Short Ratio 1496.00 % Message Board Id finmb_704589075 Shares Short Prior Month 15 M
Return On Equity -0.1784 City Brisbane Uuid a17405a3-1622-35cb-92a5-67defd12b1ed
Previous Close 13.54 First Trade Date Epoch Utc 1 B Book Value 5.51
Beta -1.52 Total Debt 2 M Volume 572546
Price To Book 2.49 Fifty Two Week Low 11.30 Total Cash Per Share 5.54
Total Revenue 101 M Shares Short Previous Month Date 1 B Target Median Price 39.00
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins 31.61 %
Target Mean Price 37.00 Net Income To Common -84293000 Short Percent Of Float 0.2235
Implied Shares Outstanding 100 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 968910 Average Volume10days 968910 Total Cash 558 M
Next Fiscal Year End 1 B Revenue Per Share 1.14 Held Percent Insiders 0.1701
Ebitda Margins -201.57 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 13.54 Target Low Price 28.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 14.35 Open 13.60
Free Cashflow -151710368 State CA Dividend Yield 0.00 %
Return On Assets -0.2543 Time Zone Short Name EST Trailing Eps -0.9700
Day Low 13.50 Address1 2000 Sierra Point Parkway Shares Outstanding 100 M
Price Hint 2 Target High Price 48.00 Website https://dayonebio.com
52 Week Change 0.1848 Average Volume 1 M Forward Eps -1.12
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 1426.80 %
Is_sp_500 False Regular Market Day High 13.78 Profit Margins -82.68 %
Debt To Equity 0.4710 Fifty Two Week High 18.07 Day High 13.78
Shares Short 18 M Regular Market Open 13.60 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 8.12 Revenue Growth 0.00 %
Shares Percent Shares Out 0.1850 Operating Cashflow -89477000 Currency USD
Time Zone Full Name America/New_York Market Cap 1 B Is_nasdaq_100 False
Zip 94005 Quote Type EQUITY Industry Biotechnology
Long Name Day One Biopharmaceuticals, Inc. Regular Market Day Low 13.50 Held Percent Institutions 0.9317
Current Price 13.72 Address2 Suite 501 Enterprise To Ebitda -4.03
Financial Currency USD Current Ratio 14.62 Gross Margins 97.75 %
Industry Disp Biotechnology Number Of Analyst Opinions 9 Country United States
Float Shares 69 M Two Hundred Day Average 14.58 Enterprise Value 827 M
Price To Sales Trailing12 Months 13.57 Forward PE -12.27 Regular Market Volume 572546
Ebitda -205504000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers.

Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma.

The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2.

Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.